Gene expression profile revealed different effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibitor on heart failure.
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000818:Animals; D001552:Benzazepines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001562:Benzimidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001713:Biphenyl Compounds; D004195:Disease Models, Animal; D004452:Echocardiography; D005355:Fibrosis / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control; D015870:Gene Expression / Q000235:genetics; D020869:Gene Expression Profiling / Q000379:methods*; D006333:Heart Failure / Q000188:drug therapy* / Q000235:genetics / Q000517:prevention & control*; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control; D007263:Infusions, Parenteral; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D020303:Rats, Inbred Dahl; D011945:Receptors, Angiotensin / Q000502:physiology / Q000627:therapeutic use; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage; D040521:Subcutaneous Tissue; D013777:Tetrazoles / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D013997:Time Factors; D016277:Ventricular Function, Left / Q000187:drug effects / Q000235:genetics
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D011945:Receptors, Angiotensin; D017673:Sodium Chloride, Dietary; D013777:Tetrazoles; C081643:candesartan; C044946:benazepril